Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trial - Mendell, J R; Sahenk, Z; Lehman, K J (Muscle Nerve, 2023)